Here are five highlights:
1. The market will grow at a compound annual growth rate of 12.5 percent between 2016 and 2021.
2. Basel, Switzerland-based Novartis, Washington, D.C.-based Danaher Corp., Tokyo, Japan-based Topcon Corp., Oberkochen, Germany-based Carl Zeiss and Wedel, Germany-based Haag-Streit Surgical lead the market.
3. Market drivers include the growing use of fluorescence image-guided surgery; rising number of minimally invasive surgeries; improving healthcare infrastructure; and increasing number of customized microscopy solutions.
4. The costliness of advanced surgical microscopes; the U.S. government excise tax; and high custom duties on medical devices will serve as obstacles to growth.
5. In 2016, the neuro/spine segment captured the largest market share, but the oncology segment will likely see the highest CAGR through 2021.
More articles on devices:
WishBone hires former Congressman Marlin Stutzman as president — 4 takeaways
Mainstay Medical’s first ReActiv8 implanted in Germany — 5 observations
Medtronic plans to sell medical supplies unit, Bloomberg reports: 6 key insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
